JP2004532863A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532863A5
JP2004532863A5 JP2002592912A JP2002592912A JP2004532863A5 JP 2004532863 A5 JP2004532863 A5 JP 2004532863A5 JP 2002592912 A JP2002592912 A JP 2002592912A JP 2002592912 A JP2002592912 A JP 2002592912A JP 2004532863 A5 JP2004532863 A5 JP 2004532863A5
Authority
JP
Japan
Prior art keywords
modafinil
povidone
composition
mixture
sol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002592912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004532863A (ja
JP4443119B2 (ja
Filing date
Publication date
Priority claimed from US10/155,913 external-priority patent/US7297346B2/en
Application filed filed Critical
Publication of JP2004532863A publication Critical patent/JP2004532863A/ja
Publication of JP2004532863A5 publication Critical patent/JP2004532863A5/ja
Application granted granted Critical
Publication of JP4443119B2 publication Critical patent/JP4443119B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002592912A 2001-05-25 2002-05-24 モダフィニルを含んで成る固体製剤 Expired - Lifetime JP4443119B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29369501P 2001-05-25 2001-05-25
US10/155,913 US7297346B2 (en) 2001-05-25 2002-05-23 Pharmaceutical formulations of modafinil
PCT/US2002/016369 WO2002096401A1 (en) 2001-05-25 2002-05-24 Solid pharmaceutical formulations comprising modafinil

Publications (3)

Publication Number Publication Date
JP2004532863A JP2004532863A (ja) 2004-10-28
JP2004532863A5 true JP2004532863A5 (https=) 2005-11-17
JP4443119B2 JP4443119B2 (ja) 2010-03-31

Family

ID=26852708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002592912A Expired - Lifetime JP4443119B2 (ja) 2001-05-25 2002-05-24 モダフィニルを含んで成る固体製剤

Country Status (19)

Country Link
US (1) US7297346B2 (https=)
EP (1) EP1397127B8 (https=)
JP (1) JP4443119B2 (https=)
KR (1) KR100911779B1 (https=)
CN (1) CN1318026C (https=)
AT (1) ATE357228T1 (https=)
AU (1) AU2002318155B8 (https=)
BR (1) BRPI0210085B8 (https=)
CA (1) CA2448456C (https=)
DE (1) DE60219005T2 (https=)
ES (1) ES2281527T3 (https=)
IL (1) IL158959A (https=)
MX (1) MXPA03010705A (https=)
MY (1) MY129376A (https=)
NO (1) NO328805B1 (https=)
NZ (1) NZ530040A (https=)
TW (1) TWI321475B (https=)
WO (1) WO2002096401A1 (https=)
ZA (1) ZA200309978B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2003529A3 (cs) 2000-07-27 2003-09-17 Teva Pharmaceutical Industries Ltd. Krystalický a čistý modafinil a postup jeho přípravy
US7067148B2 (en) 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
EP1526842A1 (en) * 2002-07-25 2005-05-04 Ranbaxy Laboratories, Ltd. Processes for the preparation of oral dosage formulations of modafinil
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
CA2420180A1 (en) * 2003-02-28 2004-08-28 Bernard Charles Sherman Tablets comprising modafinil
CA2519117C (en) * 2003-03-17 2010-03-02 Neurohealing Pharmaceuticals, Inc. High potency dopaminergic treatment of neurological impairment associated with brain injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR046410A1 (es) * 2003-09-18 2005-12-07 Cephalon Inc Composiciones farmaceuticas para la liberacion modificada de modafinilo
CN101031290B (zh) * 2003-09-18 2011-09-21 赛福伦公司 改良释放的莫达非尼药物组合物
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20050137264A1 (en) * 2003-12-22 2005-06-23 Patel Ashish A. Modafinil compositions
EP1865980A4 (en) * 2005-04-08 2009-11-11 Shire Llc ABUSEFUL AMPHETAMINE PRODRUGS
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
KR101431711B1 (ko) * 2008-05-07 2014-08-21 삼성전자 주식회사 발광 장치 및 발광 시스템의 제조 방법, 상기 방법을이용하여 제조한 발광 장치 및 발광 시스템
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
HUE037616T2 (hu) 2010-12-08 2018-09-28 Codexis Inc Biokatalizátorok és eljárások armodafinil szintéziséhez
BR112013015645A2 (pt) * 2010-12-21 2016-08-09 Akzo Nobel Chemicals Int Bv composição para cuidados pessoais
FR2987266B1 (fr) 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1570994A (en) * 1923-11-20 1926-01-26 William A Cook Spring-forming die
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
FR2706767B1 (https=) * 1993-06-22 1995-09-08 Lafon Labor
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
CA2301883A1 (en) * 1997-09-11 1999-03-18 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
WO2000037055A1 (en) 1998-12-18 2000-06-29 Abbott Laboratories Controlled release formulation of divalproex sodium
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) * 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
US6204245B1 (en) * 1999-09-17 2001-03-20 The Regents Of The University Of California Treatment of narcolepsy with immunosuppressants
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides

Similar Documents

Publication Publication Date Title
JP2004532863A5 (https=)
CA2448456A1 (en) Solid pharmaceutical formulations comprising modafinil
KR102803917B1 (ko) 루카파립의 고 용량 강도 정제
JP5553452B2 (ja) ブリバラセタムを含む医薬組成物
PT88099B (pt) Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada
JP2014028833A (ja) モダフィニルの新規の医薬製剤
KR20180109992A (ko) Jak 키나아제 억제제 또는 약학적으로 허용가능한 그의 염을 함유하는 약학적 조성물
CN1221256C (zh) 药物组合物
CN105213333A (zh) 一种他达拉非药物组合物及其制备方法
CN101312714A (zh) 替米沙坦的药用组合物
BRPI0712255A2 (pt) processo para multiparticulados usando um compactador cilìndrico
JP2013533881A (ja) バノキセリンを含有する医薬組成物
CN102846573B (zh) 水飞蓟宾双层缓释片及其制备方法
CN101011362A (zh) 匹多莫德分散片及其制备方法和应用
WO2008101375A1 (en) A gastric retentive sustained-release pharmaceutical composition comprising irbesartan
CN101744785A (zh) 速释片剂及其制备方法
RU2483718C2 (ru) Галеновые композиции алискирена
CN113368032A (zh) 药物组合物、口服固体制剂及其制备方法和用途
KR20130078147A (ko) 일정한 입도를 갖는 ４，５―디아릴―３（２ｈ）―퓨라논 유도체를 포함하는 약학 조성물
CN106822097A (zh) 一种用于减肥的含奥利司他的药物组合物
JP2008546635A (ja) バロピシタビン（ｖａｌ−ｍＣｙｄ）の固形経口投与量形態およびその製造方法
CN102198107A (zh) 拉西地平分散片及其制备方法
CN105616376A (zh) 含异甘草酸镁药物的组合物及制备方法
KR20180088929A (ko) 약학 조성물
CN113768889B (zh) 一种含西洛他唑的药物组合物及其制备方法